CoChat

Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias

Open access

The DOI matches its Crossref record; 98 of the 100 references it cites were found in a registry or an index.

Abstract

Various biomarkers are available to support the diagnosis of neurodegenerative diseases in clinical and research settings. Among the molecular imaging biomarkers, amyloid-PET, which assesses brain amyloid deposition, and 18 F-fluorodeoxyglucose ( 18 F-FDG) PET, which assesses glucose metabolism, provide valuable and complementary information. However, uncertainty remains regarding the optimal timepoint, combination, and an order in which these PET biomarkers should be used in diagnostic evaluations because conclusive evidence is missing. Following an expert panel discussion, we reached an agreement on the specific use of the individual biomarkers, based on available evidence and clinical expertise. We propose a diagnostic algorithm with optimal timepoints for these PET biomarkers, also taking into account evidence from other biomarkers, for early and differential diagnosis of neurodegenerative diseases that can lead to dementia. We propose three main diagnostic pathways with distinct biomarker sequences, in which amyloid-PET and 18 F-FDG-PET are placed at different positions in the order of diagnostic evaluations, depending on clinical presentation. We hope that this algorithm can support diagnostic decision making in specialist clinical settings with access to these biomarkers and might stimulate further research towards optimal diagnostic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(20)30314-8

Cites

98 of 98 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 98 references

Research works printed but not linked: 3

  1. McKhann, 2011, The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease, Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005 · DOI · Paper page
  2. Dubois, 2014, Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria, Lancet Neurol, 13, 614, 10.1016/s1474-4422(14)70090-0 · DOI · Paper page
  3. Garrett, 2018, A Critique of the 2018 National Institute on Aging's. Research framework: toward a biological definition of Alzheimer's disease, Curr Neurobiol, 9, 49

Cited by

See all 554

Metadata

Authors
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A., Landau, S. M., Minoshima, S., Nobili, F., Nordberg, A., Ossenkoppele, R., Oyen, W. J. G., Perani, D., Rabinovici, G. D., Scheltens, P., Villemagne, V. L., Zetterberg, H., & Drzezga, A.
Affiliations
  • Inserm (FR)
  • Clinica Universidad de Navarra (ES)
  • University Hospital Leipzig (DE)
  • University of Geneva (CH)
  • Copenhagen University Hospital (DK)
  • Ospedale Policlinico San Martino (IT)
  • Vita-Salute San Raffaele University (IT)
  • Amsterdam University Medical Centers (NL)
  • Aarhus University Hospital (DK)
  • Sorbonne Université (FR)
  • Oslo University Hospital (NO)
  • University Hospital of Geneva (CH)
  • Lund University (SE)
  • University of Manchester (GB)
  • University College London (GB)
  • Mayo Clinic (US)
  • University of California, Berkeley (US)
  • University of Utah (US)
  • Karolinska Institutet (SE)
  • Humanitas University (IT)
  • University of California, San Francisco (US)
  • Edith Cowan University (AU)
  • Sahlgrenska University Hospital (SE)
  • Forschungszentrum Jülich (DE)
Corresponding author
Chételat, Gaël
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2020-11
Volume
19
Issue
11
Pages
951-962
ISSN
1474-4422 (ISSN-L)
OpenAlex
W3093546635
Cited by
526
References
100
Citations by year
2026: 59 · 2025: 92 · 2024: 104 · 2023: 101 · 2022: 92 · 2021: 75 · 2020: 3
FWCI
49.43
Type
journal article
Language
en
Open access
Licence
Locations
  • The Lancet Neurology (acceptedVersion)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
  • Archive ouverte UNIGE (University of Geneva) (publishedVersion, cc-by)
  • HAL (submittedVersion, cc-by-nc)
  • Research Online (Edith Cowan University) (submittedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • UCL Discovery (University College London) (submittedVersion)
  • CINECA IRIS Institutial Research Information System (University of Genoa) (submittedVersion)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion)
  • Institutional Research Information System University of Turin (University of Turin) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • DZNE Pub (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity) (cc-by-nc-nd)
Funders
  • Centers for Medicare and Medicaid Services
  • American College of Radiology
  • European Association of Nuclear Medicine
  • Innovative Medicines Initiative (115952)
  • UCLH Biomedical Research Centre
  • Alzheimer's Association
  • University College London Hospitals Biomedical Research Centre
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
Keywords
amyloid PET, 18F-FDG PET, Alzheimer's disease, dementia, diagnostic algorithm, brain amyloid deposition, glucose metabolism, neurodegenerative diseases, differential diagnosis, early diagnosis, PET biomarkers, expert consensus
MeSH terms
Aged, Alzheimer Disease, Brain, Diagnosis, Differential, Humans, Male, Dementia, Vascular, Amyloid beta-Protein Precursor, Fluorodeoxyglucose F18, Positron-Emission Tomography

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. https://app.cochat.ai/papers/10.1016/s1474-4422(20)30314-8
The paper
Chételat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A. A., . . . Drzezga, A. (2020). Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias. The Lancet Neurology. https://doi.org/10.1016/s1474-4422(20)30314-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.